Kiora Share Price
NASDAQ: KPRX | Micro Cap | Healthcare$0.72
+$0.72 (--%) Last updated on 21 Nov, 2026 | 02:29 ISTKiora Stock Performance
Kiora Share Price Chart
$0.75$0.78
L
H
Kiora Quarterly Profit & Loss
All figures in USD
Kiora Annual Profit & Loss
All figures in USD
Kiora Balance Sheet
All figures in USD Million
Kiora Cash Flow
Annually
All figures in USD Million
Corporate Actions
About Kiora
Kiora Pharmaceuticals Inc is a clinical-stage biotechnology company developing and commercializing products for the treatment of orphan retinal diseases. As part of its development, KIO-301 is being studied for the treatment of retinitis pigmentosa, choroideremia, and Stargardt disease. It is a molecular photoswitch that has the potential to restore vision in patients with inherited and/or age-related retinal degeneration. KIO-104 is being developed for the treatment of posterior non-infectious uveitis. It is a next-generation, non-steroidal, immuno-modulatory, and small-molecule inhibitor of dihydroorotate dehydrogenase.
Kiora Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Nov 2026 | $1.79 | $0.75 | -53.13% |
Oct 2026 | $2.55 | $1.60 | -41.18% |
Sep 2026 | $2.54 | $2.72 | +3.82% |
Aug 2026 | $2.61 | $2.62 | +5.22% |
Jul 2026 | $2.67 | $2.49 | -4.41% |
Jun 2026 | $2.71 | $2.60 | -4.58% |
May 2026 | $2.40 | $2.73 | +15.68% |
Apr 2026 | $1.90 | $2.36 | +24.87% |
Mar 2026 | $2.02 | $1.89 | -7.35% |
Feb 2026 | $2.40 | $2.04 | -14.47% |
Jan 2026 | $1.99 | $2.38 | +22.31% |
Dec 2025 | $1.92 | $1.95 | +2.63% |